Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wisconsin R&D Windfall Bids To Make Entrepreneurs Of Academics

This article was originally published in The Gray Sheet

Executive Summary

Medical technology researchers on the University of Wisconsin-Madison faculty will be encouraged to commercialize their findings under a state government initiative costing roughly $750 mil

You may also be interested in...



Stem cell bioengineered skin

U.S. BioDefense, Inc. files for Small Business Innovation Research Grant to support development of its stem-cell technology for the creation of skin grafts to treat skin wounds. The company is focused on the treatment of vesicant-agent-induced cutaneous burns that would result from a mustard gas or other biological weapon attack. The City of Industry, Calif.-based firm is taking advantage of California Proposition 71, which approved an unprecedented $3 bil. investment in stem-cell research funding over the next decade. Wisconsin also is looking to fund stem cell research (1"The Gray Sheet" Nov. 29, 2004, p. 13)...

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.

UsernamePublicRestriction

Register

MT021254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel